Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Dec 20, 2024
Open Peer Review Period: Dec 20, 2024 - Feb 14, 2025
Date Accepted: Apr 3, 2025
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

The State of Remote Patient Monitoring for Chronic Disease Management in the United States

Paul MM, Khera N, Elugunti PR, Ruff KC, Hommos MS, Thomas LF, Nagaraja V, Garrett AL, Pantoja-Smith M, Delafield NL, Lizaola-Mayo BC, Kresin MM, Seetharam M, Nagarakanti SR, Kaur M

The State of Remote Patient Monitoring for Chronic Disease Management in the United States

J Med Internet Res 2025;27:e70422

DOI: 10.2196/70422

PMID: 40570326

PMCID: 12246758

The state of remote patient monitoring for chronic disease management in the United States

  • Margaret M. Paul; 
  • Nandita Khera; 
  • Praneetha R. Elugunti; 
  • Kevin C. Ruff; 
  • Musab S. Hommos; 
  • Leslie F. Thomas; 
  • Vivek Nagaraja; 
  • Ashley L. Garrett; 
  • Mari Pantoja-Smith; 
  • Nathan L. Delafield; 
  • Blanca C. Lizaola-Mayo; 
  • Molly M. Kresin; 
  • Mahesh Seetharam; 
  • Sandhya R. Nagarakanti; 
  • Manreet Kaur

ABSTRACT

Remote patient monitoring (RPM) increased exponentially during the COVID-19 pandemic. RPM programs commonly incorporate tools to capture and transmit health relevant data from the home to the clinical space to augment the clinical decision-making process of health care providers. Examples of data captured include patient behaviors such as degree of medication adherence and physical activity, safety-related events such as falls, and physiological parameters such as blood pressure and blood glucose concentration. In some cases, real-time analysis of captured data may be performed to enable rapid clinical decision-making. Given the potential to improve patient health outcomes, healthcare systems around the world are actively engaged in fashioning, implementing, and exploring the outcomes of various RPM program models, each envisioned to improve patient care in a sufficiently effective and efficient manner to produce value. However, new challenges to healthcare systems include increasing RPM program enrollment, optimizing condition-specific RPM programs to best address the needs of specific patient groups, integrating new RPM-derived data streams into existing information technology infrastructures, overcoming limited availabilities of desired remote monitoring technologies, and quantifying the health outcomes produced by RPM utilization. Herein, we identify stakeholders for RPM in the US, summarize the landscape of RPM tools available for chronic disease management, discuss the current regulatory environment, delve into the benefits and challenges of integrating these tools into clinical practice, summarize aspects of coverage and reimbursement, and examine the knowledge gaps regarding sustained use of RPM in clinical practice along with associated opportunities.


 Citation

Please cite as:

Paul MM, Khera N, Elugunti PR, Ruff KC, Hommos MS, Thomas LF, Nagaraja V, Garrett AL, Pantoja-Smith M, Delafield NL, Lizaola-Mayo BC, Kresin MM, Seetharam M, Nagarakanti SR, Kaur M

The State of Remote Patient Monitoring for Chronic Disease Management in the United States

J Med Internet Res 2025;27:e70422

DOI: 10.2196/70422

PMID: 40570326

PMCID: 12246758

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.